pcDNA3.1-CFP-KRAS4B Citations (1)
Originally described in: KRAS Dimerization Impacts MEK Inhibitor Sensitivity and Oncogenic Activity of Mutant KRAS.Ambrogio C, Kohler J, Zhou ZW, Wang H, Paranal R, Li J, Capelletti M, Caffarra C, Li S, Lv Q, Gondi S, Hunter JC, Lu J, Chiarle R, Santamaria D, Westover KD, Janne PA Cell. 2018 Feb 8;172(4):857-868.e15. doi: 10.1016/j.cell.2017.12.020. Epub 2018 Jan 11. PubMed Journal
Articles Citing pcDNA3.1-CFP-KRAS4B
Articles |
---|
TAK1 Phosphorylates RASSF9 and Inhibits Esophageal Squamous Tumor Cell Proliferation by Targeting the RAS/MEK/ERK Axis. Shi H, Ju Q, Mao Y, Wang Y, Ding J, Liu X, Tang X, Sun C. Adv Sci (Weinh). 2021 Jan 6;8(5):2001575. doi: 10.1002/advs.202001575. eCollection 2021 Mar. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.